Observational × Head and Neck Neoplasms × Dermatologic × Clear all SHERLOCK
Recruiting
7,000 enrolled
DP-04
Recruiting
100 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
SCORE
Recruiting
9,600 enrolled
SPECIAL
Active not recruiting
14 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
LIBERATE
Recruiting
2,500 enrolled
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Active not recruiting
1,150 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
DELFI-L101
Completed
2,992 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
PREFER
Completed
1,429 enrolled
MOM
Completed
40 enrolled
EVIDENT
Recruiting
600 enrolled
MOHCCN-O
Recruiting
500 enrolled
ROOT
Completed
167 enrolled
OCTANE
Recruiting
10,000 enrolled
SkinHealth
Recruiting
420 enrolled
POSITive
Unknown
265 enrolled
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Terminated
20 enrolled
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
Unknown
425 enrolled
G-DEFINER
Completed
247 enrolled
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Terminated
22 enrolled
PIONEER
Unknown
1,000 enrolled
EPR Tumor Oximetry With CE India Ink
Terminated
3 enrolled
N1
Terminated
23 enrolled
Assessing the Patient Experience in Cancer Care
Completed
408 enrolled
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
TEST
Terminated
2 enrolled
Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer
Completed
289 enrolled